date,title,source
Oct-19-18,Deciphera Pharmaceuticals Reports Updated Preliminary Phase 1 Clinical Study Results with DCC-2618 at the European Society of Medical Oncology (ESMO) 2018 Congress,Business Wire
Oct-23-18,"New Research Coverage Highlights Griffon, SEACOR, Deciphera Pharmaceuticals, Clearwater Paper, Comtech Telecommunications, and United Natural Foods  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-23-18,"Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors",Business Wire
Nov-08-18,"Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results",Business Wire
Nov-15-18,Deciphera Pharmaceuticals Completes Enrollment in the INVICTUS Pivotal Phase 3 Clinical Study of DCC-2618 in Patients with Advanced Gastrointestinal Stromal Tumors,Business Wire
